Dean Gregory
Patrimonio netto: 253 237 $ in data 30/06/2026
Patrimonio netto: 253 237 $ in data 30/06/2026
Dean A. Gregory is currently Director at Illinois Biotechnology Industry Organization and Independent Director at Cerus Corp.
since 2024.
Formerly, Mr. Gregory was President-Medical Devices at Fresenius Kabi Pharmaceuticals Holding, Inc. (United States) from 2012 to 2024, Senior Vice President-Sales & Operations at Fenwal, Inc. from 2010 to 2012, and VP-Business Development, Strategy & Marketing ROW at Baxter International, Inc. from 2002 to 2007.
Education includes an MBA from DePaul University and an undergraduate degree from the University of Illinois.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
CERUS CORPORATION 0,04% | 02/06/2026 | 86.725 ( 0,04% ) | 253 237 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CERUS CORPORATION | Direttore/Membro del Consiglio | 01/07/2024 |
Illinois Biotechnology Industry Organization
Illinois Biotechnology Industry Organization Miscellaneous Commercial ServicesCommercial Services Life science industry association | Direttore/Membro del Consiglio | 20/01/2010 |
| Società | Posizione | Fine |
|---|---|---|
Fresenius Kabi Pharmaceuticals Holding, Inc. (United States)
Fresenius Kabi Pharmaceuticals Holding, Inc. (United States) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | 01/03/2024 |
Fenwal, Inc.
Fenwal, Inc. BiotechnologyHealth Technology Manufactures blood collection and transfusion systems | Direttore operativo | 18/03/2010 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01/02/2007 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 7 |
|---|---|
Baxter International, Inc.
Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Cerus Corp.
Cerus Corp. Medical SpecialtiesHealth Technology Develops and commercializes the INTERCEPT Blood System for platelets and plasma | Health Technology |
DePaul University
DePaul University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois
University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fenwal, Inc.
Fenwal, Inc. BiotechnologyHealth Technology Manufactures blood collection and transfusion systems | Health Technology |
Illinois Biotechnology Industry Organization
Illinois Biotechnology Industry Organization Miscellaneous Commercial ServicesCommercial Services Life science industry association | Commercial Services |
Fresenius Kabi Pharmaceuticals Holding, Inc. (United States)
Fresenius Kabi Pharmaceuticals Holding, Inc. (United States) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale